A Longitudinal Study to Identify Mechanisms of Menopause on Cardiovascular Disease Risk

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age40-61
SponsorUniversity of Copenhagen

About this trial

With the cessation of estrogen production at menopause, the risk of cardiovascular disease like arthrosclerosis, myocardial infarction and stroke increases dramatically. Physical activity is the single most powerful "drug" for maintaining and improving cardiovascular health, but recent data suggest that the positive effect of physical activity is lost at menopause. In this project the investigators will follow a cohort of 200 women from before the women enter menopause and until at least 10 years past menopause. By advanced invasive methodologies the investigators will monitor the changes that occur in the blood vessels of the circulation, the heart and the brain and combine this with microRNA sequencing of blood and tissue samples.

Eligibility criteria

Qualifiers

Normal ECG

Regular menstruation

Disqualifiers

Participation in other clinical projects

Smokes or has smoked within the last 10 years

On hormone therapy

Has chronic diseases that are not expected, cf. the groups sought. Including heart problems, atrial fibrillation, cancer, immune diseases and previous strokes with functionally significant sequelae

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators